Cognitive therapy vs medications in the treatment of moderate to severe depression

Archives of General Psychiatry

Volumn 62, Issue 4, 2005, Pages 409-416

  DeRubeis, Robert J ^a   Hollon, Steven D ^b   Amsterdam, Joy D ^a   Shelton, Richard C ^b   Young, Paula R ^a   Salomon, Ronald M ^b   O'Reardon, John P ^a   Lovett, Margaret L ^b   Gladis, Madeline M ^a   Brown, Laurel L ^b   Gallop, Robert ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c WEST CHESTER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; DESIPRAMINE; LITHIUM CARBONATE; PAROXETINE; PLACEBO; SERTRALINE; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; FOLLOW UP; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTPATIENT; PSYCHOTHERAPIST; RANDOMIZED CONTROLLED TRIAL; REMISSION; SIDE EFFECT; TREATMENT OUTCOME;

ADULT; AMBULATORY CARE; ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; DEPRESSIVE DISORDER; DESIPRAMINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM CARBONATE; MALE; PAROXETINE; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 20144388844     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.62.4.409     Document Type: Article

References (34)

1. Olfson M, Klerman GL. Trends in the prescription of antidepressants by office-based psychiatrists. Am J Psychiatry. 1993;150:571-577.
2. Thase ME, Kupfer DJ. Recent developments in the pharmacotherapy of mood disorders. J Consult Clin Psychol. 1996;64:646-659.
3. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. New York, WY: Guilford Press: 1979.
4. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry. 2000;157 (suppl 4):1-45.
5. Rush AJ, Beck AT, Kovacs M, Hollon S. Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed patients. Cognit Ther Res. 1977;1:17-37.
6. Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Collins JF, Glass DR, Pilkonis PA, Leber WR, Docherty JP, Fiester SJ, Parloff MB. NIMH Treatment of Depression Collaborative Research Program: general effectiveness of treatments. Arch Gen Psychiatry. 1989;46:971-982.
7. Elkin I, Gibbons RD, Shea MT, Sotsky SM, Watkins JT, Pilkonis PA, Hedeker D. Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol. 1995;63:841-847.
8. Jacobson NS, Hollon SD. Cognitive-behaviortherapy versus pharmacotherapy: now that the jury's returned its verdict, it's time to present the rest of the evidence. J Consult Clin Psychol. 1996;64:74-80.
9. Murphy GE, Simons AD, Wetzel RD, Lustman PJ. Cognitive therapy and pharmacotherapy. Arch Gen Psychiatry. 1984;41:33-41.
10. Hollon SD, DeRubeis RJ, Evans MD, Wiemer MJ, Garvey MJ, Grove WM, Tuason VB. Cognitive therapy and pharmacotherapy for depression: singly and in combination. Arch Gen Psychiatry. 1992;49:774-781.
11. DeRubeis RJ, Gelfand LA, Tang TZ, Simons AD. Medications versus cognitive behavioral therapy for severely depressed outpatients: mega-analysis of four randomized comparisons. Am J Psychiatry. 1999;156:1007-1013.
12. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition With Psychotic Screen (SCID-I/P W/ PSY SCREEN). New York: Biometrics Research, New York State Psychiatric Institute; 2001.
13. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II, Version 1.0). Washington, DC: American Psychiatric Press; 1990.
14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960; 23:56-62.
15. Williams JB. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry. 1988;45:742-747.
16. Reimherr FW, Amsterdam JD, Quitkin FM, Rosenbaum JF, Fava M, Zajecka J, Beasley CM, Michelson D, Roback P, Sundell K. Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment. Am J Psychiatry. 1998;155:1247-1253.
17. Fleiss JL, Cohen J. Statistical Methods for Rates and Proportions. New York: John Wiley & Sons; 1973.
18. American Psychological Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychological Association; 1994.
19. Hollon SD, DeRubeis RJ, Shelton RC, Amsterdam JD, Salomon RM, O'Reardon JP, Lovett ML, Young PR, Haman KL, Freeman BB, Gallop R. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry. 2005;62:417-422.
20. Hollon SD, Thase ME, Markowitz JC. Treatment and prevention of depression. Psychological Science in the Public Interest. 2002;3:39-77.
21. Fawcett J, Epstein P, Rester SJ, Elkin I, Autry JH. Clinical management-imipramine/placebo administration manual: NIMH Treatment of Depression Collaborative Research Program. Psychopharmacol Bull. 1987;23:309-324.
22. Beck JS. Cognitive Therapy: Basics and Beyond. New York, NY: Guilford Press; 1995.
23. Beck AT, Freeman A. Cognitive Therapy of Personality Disorders. New York, NY: Guilford Press; 1990.
24. Amsterdam JD, Brunswick DJ, Gilbertini M. Sustained efficacy of gepirone-IR in major depressive disorder: a double-blind placebo substitution trial. J Psychiatr Res. 2004;38:259-265.
25. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991;48:851-855.
26. Kuritz SJ, Landis JR, Koch GG. A General overview of Mantel-Haenszel methods: applications and recent developments. Annu Rev Public Health. 1988; 9:123-160.
27. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: Wiley; 1989.
28. Stokes ME, Davis CS, Koch GG. Categorical Data Analysis Using the SAS System. Gary, NC: SAS Institute Inc; 1995.
29. Bryk A, Raudenbush S. Hierarchical Linear Modeling: Applications and Data Analysis Methods. Newbury Park, Calif: Sage Publishing; 1996.
30. Goldstein H. Models in Educational and Social Research. New York, NY: Oxford University Press; 1987.
31. Raudenbush SW, Xiao-Feng L. Effects of study duration, frequency of observation, and sample size on power in studies of group differences in polynomial change. Psychol Methods. 2001;6:387-401.
32. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
33. Klein DF. Preventing hung juries about therapy studies. J Consult Clin Psychol. 1996;64:74-80.
34. Jacobson NS, Hollon SD. Prospects for future comparisons between drugs and psychotherapy: lessons from the CBT-versus-pharmacotherapy exchange. J Consult Clin Psychol. 1996;64:104-108.